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Abstract: Cell therapies require the in vitro expansion of adherent cells such as mesenchymal stromal cells (hMSCs) in 
bioreactor systems or other culture environments, followed by cell harvest. As hMSCs are strictly adherent cells, cell 
harvest requires cell detachment. The use of hMSCs for cell therapy requires GMP production in accordance with the 
guidelines for advanced therapeutic medical products. Therefore, several GMP-conform available proteolytic enzymes 
were investigated for their ability to promote hMSC detachment. An allogeneic hMSC cell line (hMSC-TERT) that is 
used in clinical trials in the form of alginate cell capsules was chosen as a model. This study investigated the influence of 
several factors on the outcome of proteolytic hMSC-TERT detachment. Therefore, hMSC-TERT detachment was 
analyzed in different cultivation systems (static, dynamic) and in combination with further cell processing including 
encapsulation. Only two of the commercially available enzymes (AccutaseTM, TrypZeanTM) that fulfill all process 
requirements (commercial availability, cost, GMP conditions during manufacturing and non-animal origin) are found to 
be generally suitable for detaching hMSC-TERT. Combining cell detachment with encapsulation demonstrated a high 
impact of the experimental set up on cell damage. It was preferable to reduce the temperature during detachment and limit 
the detachment time to a maximum of 20 minutes. Cell detachment in static systems was not comparable with detachment 
in dynamic systems. Detachment yields in dynamic systems were lower and cell damage was higher for the same 
experimental conditions. Finally, only TrypZeanTM seemed to be suitable for the detachment of hMSC-TERT from 
dynamic reactor systems. 
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1. INTRODUCTION 
 Stem cells are one of the most important tools in cell 
therapy. They can be used to treat many diseases including 
diabetes mellitus and stroke [1]. In particular, human 
148    The Open Biomedical Engineering Journal, 2013, Volume 7 Salzig et al. 
mesenchymal stromal cells (hMSC) are highly promising for 
further applications in cell therapy. One example of the use 
of hMSCs in cell therapy is the CellBead
®
 technology 
(CellMed AG, a subsidiary of BTG plc.). CellBead
®
 is an 
implantable cell therapeutic system based on a genetically 
modified hMSC cell line (hMSC-TERT) encapsulated in 
alginate, and is under a clinical trial for stroke treatment 
(clinical trial number: NCT01298830). The microcapsules 
enable the application of allogeneic stem cells without 
“graft-versus-host-disease” [2]. 
 As stem cells become increasingly important for 
therapeutic treatments, enormous amounts of these cells will 
need to be produced. This is critical, because hMSCs only 
grow in adherent culture. Based on a therapeutic dose 
ranging from 1.5 to 120 · 10
6
 hMSCs [3] and a maximum 
expansion of 100,000 hMSCs per cm
2
, a growth surface of 
between 10 and 1,200 cm
2
 is required for a single dose. 
When using allogeneic hMSCs, the cell therapeutic can be 
produced as a stock. In this case, one production process 
should yield 100 doses. This means that a growth surface as 
large as 120,000 cm
2
 could be required, corresponding to 
400 T-300 flasks to produce only 100 doses. Similar 
amounts of cells can be easily obtained using one 6.4 L fixed 
bed reactor or one 22 L stirred tank reactor. Bioreactors 
present advantages including low personnel demand, high 
space-time yield, a high level of automation of the 
cultivation, and a high level of control over the cell harvest 
and process control [4]. In conclusion, bioreactors should be 
the system of choice for hMSC expansion. 
 The hMSC production process is special in that the 
expanded cell is the product itself. In conventional processes 
such as antibody production, the production cells are 
discarded at the end of the process. In a stem cell expansion 
process, the production cell has to be harvested and removed 
from the reactor vessel in a high amount and at a high 
viability. 
 In this study, the hMSC-TERT cell line was used as a 
representative of therapeutically applied hMSCs. As hMSC-
TERT are adherently growing cells, carriers can be used to 
provide a suitable growth surface for a bioreactor expansion 
[5]. For the hMSC-TERT expansion processes in this work, 
non-porous and uncoated glass carriers were chosen. These 
carriers have been shown to be ideal as they on the one hand 
promote enough cell attachment and cell growth for an 
efficient expansion and on the other hand enable cell 
detachment [5]. This is not naturally given for all carriers as 
most of them are only optimized for strong cell adherence 
but not for cell detachment. With suitable carriers hMSC can 
be expanded in several cultivation systems. Many are known 
for their applicability to hMSC expansion, including fixed 
bed systems [4, 6, 7] and stirred tank reactors [3, 8]. The 
common characteristic of all hMSC expansion systems is 
that the adherent stem cells have to be detached from the 
growth surface at the end of the expansion process.  
 One standard method of hMSC detachment is proteolytic 
cleavage via proteases. The cell adherence in vitro is based 
on peptide bonds formed between medium proteins and 
extracellular cell surface proteins [9]. Positive charged 
medium proteins (mainly serum proteins as fibronectin (pI 
5.3)) adsorb to the negative charged plastic or glass surfaces. 
Based on electrostatic interactions negative charged cells 
stick to the medium proteins. Finally covalent bonds were 
formed between the protein surface layer and integrins on the 
cell surface. As a consequence of this mode of attachment, 
adherent cells can be detached via proteolytic cleavage. The 
most commonly used protease for this purpose is bovine or 
porcine trypsin isolated from the pancreas. Despite its 
widespread use, trypsin presents several disadvantages for 
the detachment of cells that will be used therapeutically. 
First, trypsin is of animal origin. hMSCs used as advanced 
therapeutic medical products (ATMPs) fall under the 
guidance of the American Food and Drug Administration 
(FDA) and the European Medicines Agency (EMA). These 
guidelines hold that the amount of raw materials of animal 
origin used during the production of ATMPs should be 
minimized because of ethical and safety reasons [10]. 
Second, longer incubation times with trypsin can result in 
irreversible damage to the cell surface proteins [11], which 
would interfere with the aim of producing highly viable 
hMSCs for therapeutic application. For example, strong 
trypsinization of neural stem cells led to a reduction in cell 
viability and growth. This outcome was caused by the 
destruction of membrane receptors and cell adhesion 
molecules [12]. Third, trypsin should be used for hMSC 
expanded in a bioreactor system and for hMSCs which will 
be encapsulated after detachment. At first glance this has 
nothing to do with each other. On a closer look, however, it 
becomes apparent that the enzyme must fit to the cultivation 
system and to the further processing of the cells. In 
bioreactors dynamic cultivation is performed which causes 
higher cell stress during cell growth. Similar to that an 
encapsulation procedure applies shear stresses to the 
detached cells. Shear stress during cell growth and further 
cell processing means that the cells are handicapped and not 
as robust against potential damage from the detachment 
enzyme. Moreover, the forces responsible for cell 
detachment differ between dynamic (e.g., bioreactors) and 
static systems (e.g., T-flasks). In static systems, the 
enzymatic detachment is promoted by tapping. The tapping 
results in brief but strong shear forces that help to detach the 
cells. In contrast, tapping is not possible in dynamic systems. 
After enzymatic cleavage, detached cells are simply flushed 
out of the reactor. The resulting shear forces of the fluid flow 
are much weaker than those resulting from tapping. In 
consequence the detachment enzyme must be very efficient 
in dynamic systems as detachment is not supported by 
mechanical forces. Therefore, the enzymatic cleavage of 
hMSCs grown on carriers in dynamic systems must be as 
efficient but also as gentle as possible. Therefore, 
mammalian trypsin has certain disadvantages for the harvest 
of therapeutic stem cell products.  
 As summarized in Table 1, several other enzymes tend to 
be suitable for hMSC detachment in an ATMP production 
process. Out of this list four enzyme candidates (Accutase
TM
, 
Alfazyme, Collagenase and TrypZean
TM
) were favored 
considering additional characteristics including commercial 
availability, cost, GMP conditions during manufacturing and 
non-animal origin. These enzymes have already been used to 
remove various adherent cells from culture surfaces but 
never for the detachment of bioreactor-expanded hMSCs. 
Accutase
TM
 (PAA)
 
contains a mixture of proteases and 
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collagenases from invertebrate species, and has already been 
successfully used in stem cell detachment experiments. The 
viability, proliferation rate and pluripotency of human 
embryonic cells did not change after treatment with 
Accutase
TM 
[13]. In contrast to trypsin treatment, Accutase
TM
 
does not affect the extracellular matrix (ECM) proteins [11]. 
Neural stem cells detached with Accutase
TM
 had a viability 
of 90 to 95 % compared with 70 to 80 % after trypsin 
treatment [12]. Alfazyme (PAA) contains a mixture of 
proteolytic and collagenolytic enzymes as well as long 
glucane polymers with a strong negative charge. These 
glucane polymers are able to increase cell stability after 
detachment and thus to increase cell viability 
(www.paa.com). Vielreicher et al. demonstrated that the cell 
membranes of CHO cells (chinese hamster ovary) were not 
modified even after one hour treatment with Alfazyme at 
37°C [14]. Related to stem cell detachment, Alfazyme has 
also been used to dissociate neural stem cell neurospheres 
[15]. Collagenase is a neutral protease without cytotoxic 
effects [16] and can also be used for cell detachment. Human 
embryonic stem cells have already been harvested from the 
cultivation surface using collagenase, with a viability of 
88 % after enzymatic treatment [17]. TrypZean
TM
 (Sigma-
Aldrich) is a recombinant trypsin variant produced in corn. 
In contrast to animal-derived trypsin, TrypZean
TM
 is 
naturally free of animal contaminants. Rourou et al. used 
TrypZean
TM 
to detach Vero cells. In comparison with other 
enzymes, cells detached with TrypZean
TM
 achieved the 
highest cell division number after enzymatic treatment [18]. 
TrypZean
TM
 has also been successfully used to harvest 
human MSCs for cardiac repair [19]. 
 This study investigates the enzymatic detachment of 
therapeutic mesenchymal stromal cells grown on glass 
surfaces in static and dynamic cultivation systems. The 
ATMP model cell line hMSC-TERT was chosen for these 
experiments. As it is the aim to investigate alternatives to 
standard trypsin, four enzyme candidates (Accutase
TM
, 
Alfazyme, Collagenase and TrypZean
TM
) were selected. The 
first part of the study analyzes the detachment efficiency of 
the enzymes in static systems. Detachment time and 
temperature were varied to find the best enzyme candidate 
and the best parameters for further experiments. The 
experiments were evaluated in terms of detachment 
efficiency and the survival and viability of the cells directly 
after the harvest and after encapsulation in alginate. The 
second part of the study involved the investigation of cell 
detachment in dynamic systems. Therefore, hMSC-TERT 
cells expanded in different dynamic systems (fixed-bed 
reactor and stirred tank reactor) were harvested by the most 
Table 1. Enzymes for the Harvest or Subcultivation of Mammalian Adherent Cells 
Name Origin Type Reference 
AccutaseTM Invertebrates  Mixture of collagenolytic and proteolytic enzymes [25] 
Alfazyme Invertebrates … “long glucane polymers with a strong negative charge and mild 
acting enzymes with proteolytic and collagenolytic activities”… 
(www.paa.com) 
 
Dispase Bacillus polymyxa Neutral protease, 
an amino-endo peptidase 
(www.invitrogen.com), 
cleaves fibronectin and type IV collagen 
[26] 
Elastase 
(EC 3.4.21.36) 
Mammalian pancreas Neutral protease, 
hydrolysis of proteins 
[27] 
Ficin 
(EC 3.4.22.3) 
Fig latex Protease (cysteine endopeptidase) [28] 
Collagenase  
(EC 3.4.24.3) 
Clostridium histolyticum Mixture of various enzymes, 
low tryptic, high collagenase- and normal clostripain activity 
[16] 
Mycolysin 
(EC 3.4.24.31) 
(formerly: Pronase, EC 3.4.24.4) 
Streptomyces griseus “...preferential cleavage between two hydrophobic amino acids...” [9] [29] 
Thermolysin 
(EC 3.4.24.27) 
Bacillus thermoproteolyticus Thermostable enzyme, metallopeptidase, endoprotease  [30] 
TrypLE Euphausia pacifica Trypsin-like, proteolytic activity 
(www.invitrogen.com) 
[31, 32] 
Trypsin  
(EC 3.4.21.4) 
Mammalian pancreas serine protease, relatively nonspecific cleavage of peptide bonds [33] 
TrypZeanTM recombinant recombinant, expressed in corn [34] 
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promising enzyme candidates. The outcome of the cell 
detachment was analyzed as described above for the 
detachment efficiency and cell status. 
2. MATERIALS AND METHODS 
2.1. Cultivation of hMSC-TERT in 6-well Plates 
 This study used a hMSC cell line (hMSC-TERT) [20]. 
Cultivation and harvest of hMSC-TERT were performed 
according to standard procedures [5]. hMSC-TERT were 
cultured in 6-well plates (Techno Plastic Products AG, 
Trasadingen, Austria). To ensure comparability with the 
dynamic expansion process on borosilicate glass carriers in a 
fixed bed or stirred tank reactor, borosilicate glass plates 
(Thermo Scientific Mezel- Gläser, Braunschweig, Germany) 
with a diameter of 32 mm were placed in the wells. Wells 
were filled with 3 mL MEM cultivation media (PAA, 
Pasching, Austria), supplemented with 2 mM L-Glutamine 
(PAA, Pasching, Austria) and 10 % (v/v) FCS (Fetal Calf 
Serum) (PAA, Pasching, Austria), and maintained at 37°C 
and 5 % CO2 in an incubator (MMMgroup, Planegg, 
Germany). Cells were harvested at 80 % confluence from a 
tissue culture flask (T-flask) (Sarstedt, Nümbrecht, 
Germany) following the standard procedure and seeded in 
the well plates at a density of 10,000 or 15,000 cells/cm², 
depending on the day of harvest. hMSC-TERT were grown 
to a cell density of 80,000 cells/cm². 
2.2. Cell harvest from Static Systems 
 Four different enzyme solutions were tested. Accutase
TM 
(400-600 U/mL, Sigma-Aldrich Chemie GmbH, Munich, 
Germany), Alfazyme (U/mL not specified, PAA, Pasching, 
Austria) and TrypZean
TM 
(U/mL not specified, Sigma-
Aldrich Chemie GmbH, Munich, Germany) are 
commercially available ready-to-use solutions. Collagenase 
NB 4G (from Cl. Hyistolyticum, 0.27 PZU/mg, SERVA 
Electrophoresis GmbH, Heidelberg, Germany) was dissolved 
in phosphate buffered saline (PBS) without Ca
2+
/Mg
2+
 (PAA, 
Pasching, Austria) to a concentration of 0.18 U/mL. 
Trypsin/EDTA (ready to use solution, PAA) was used as 
control. 
 The cell culture medium in the wells was removed and 
discarded. hMSC-TERT monolayers were rinsed twice with 
1 mL PBS without Ca
2+
/Mg
2+
. Then, 1 mL of the 
corresponding enzyme solution was added. Incubation with 
the enzyme solution was done at 21°C or 37°C for at least 60 
min. According to the manufacturers’ recommendations, the 
enzymatic reactions of Accutase
TM
, Alfazyme and 
TrypZean
TM 
were stopped using 1 mL sera-containing 
cultivation media. The reaction of the enzyme collagenase 
was stopped with bovine serum albumin (5 mg/mL) (Carl 
Roth GmbH, Karlsruhe, Germany). After gently pipetting of 
the stop solution on the cell layer, the layers were analyzed 
by microscopy (Leica Microsystems GmbH, Wetzlar, 
Germany) and the supernatant was removed. The cells in the 
supernatant were kept for encapsulation and further analysis. 
2.3. Cell Harvest from the Fixed-Bed Reactor 
 hMSC-TERT were expanded on spherical borosilicate 
carriers (Worf, Mainz, Germany; Ø 2 mm) in a 100 cm
3
 
fixed-bed system. Detailed information concerning the 
reactor set-up and the cultivation parameters were previously 
described [6]. To detach the cells, the medium was removed 
and the fixed-bed was washed with 200 mL PBS in perfusion 
mode (ν = 1.8 x 10-4 m s-1). Thirty mL of the enzyme 
solution was pumped into the reactor (ν = 1.8 x 10-4 m s-1) 
and the cells were incubated for 10 to 20 min at 21°C. At the 
end of the incubation time, detached cells and enzyme 
solution were flushed out of the system with 200 mL cell 
culture medium (ν =3.2 x 10-3 m s-1). Cells were kept for 
encapsulation and further analysis. 
2.4. Cell harvest from the Stirred Tank Reactor 
 hMSC-TERT were grown on polystyrene carriers coated 
with high silica glass (Solohill glass, Solohill Engineering, 
Ann Arbor, USA; Ø 125-212 µm) in a 3 L stirred tank 
reactor. Reactor setting and cultivation parameters were 
previously described [8]. For cell harvest, 350 mL of the 
cell-carrier suspension was removed. Using a 100 µm sieve, 
the medium was removed from the carriers with cells. The 
hMSC-TERT on the carrier were washed with 50 mL PBS-
Ca
2+
/Mg
2+
 and incubated with 16 mL enzyme solution for 
15 min at 21°C. To stop the detachment, 50 mL of cell 
culture medium were added. Detached cells were rinsed 
through the sieve with the medium. The harvested cells were 
kept for encapsulation and further analysis.  
2.5. Quantification of Detachment 
 In static systems the detachment efficiency was 
determined as followed. Cells were grown to a final density 
of 80,000 cells cm
-2
 and detached as described above. During 
the detachment period, detached cells were quantified in 3 
wells of a 6-well plate. Detachment reaction was stopped and 
the supernatant of these wells was removed. The cells in the 
supernatant (=detached cells) were counted by the Trypan 
blue method (Biowest, Neuville, France) following a 
standard procedure [21]. The detachment efficiency was 
calculated using equation 1: 
                       
                                
                 
 
 1) 
 In dynamic systems the detachment was quantified very 
similar. At the end of the detachment period the cells in the 
supernatant were counted by the Trypan blue method. Cells 
remaining on the carriers after detachment were determined 
by a SybrGreen assay [22]. The detachment efficiency in 
dynamic systems was calculated using equation 2. 
                      
 
                                
                                                           
 
 (2) 
2.6. Encapsulation of hMSC-TERT  
 After harvest, the cells were encapsulated in alginate. 
hMSC-TERT cells were resuspended at a concentration of 
5 x 10
6
 cells in 5 mL of 5 mM NaCl-His and gently mixed 
with 1.5 % (w/v) alginate (Carl Roth GmbH, Karlsruhe, 
Germany) using a 1 mL syringe (B. Braun, Melsungen, 
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Germany) and a G21 cannula. Droplets were formed by 
pipetting the mixture in a 20 mM BaCl2 bath. After 
incubation in 20 mM BaCl2 for 60 min, the spherical beads 
(Ø500µm) were washed 3x with PBS with Ca
2+
/Mg
2+
 (PAA, 
Pasching, Austria). Afterwards, the cell capsules were 
recultivated for 48 h in 1 mL MEM medium in a 6-well-plate 
in an incubator at 5 % CO2 and 37°C. 
2.7. Live-dead-Staining of Alginate Encapsulated Cells  
 To prepare the staining solution, a SybrGreen (Sigma-
Aldrich Chemie GmbH, Munich, Germany) working 
solution was prepared containing 20 % SybrGreen (1:500 in 
DMSO, Dimethylsulfoxide), 60 % Tris-HCl- buffer (20 mM, 
pH 8) and 20 % EDTA (100 mM, pH 8). The staining 
solution was prepared by mixing 87 % PBS with Ca
2+
/Mg
2+
, 
4.4 % propidium iodide (5 g/L) and 8.6 % SybrGreen 
(working solution). Staining was performed direct after 
encapsulation, after 24 h and 48 h recultivation. The capsules 
were washed 3x with 1 mL PBS-Ca
2+
/Mg
2+
 per 1 mL 
capsules to remove the remaining serum containing media. 
Then, 200 µL of staining solution was added and incubated 
for 5 min at room temperature in the dark. After incubation, 
the capsules were washed again with 1 mL PBS-Ca
2+
/Mg
2+
 
(5x). The live-dead analysis was performed microscopically. 
2.8. Quantitative Analysis of the Live-Dead-Staining of 
Alginate Encapsulated Cells 
 Using a fluorescence microscope (DMI6000; Leica 
Microsystems GmbH, Wetzlar, Germany) and a HCX PL 
FLUOTAR 10.0x0.30 DRY objective, pictures of the stained 
capsules were taken. Using a constant setting each 
fluorescence canal was saved separately. The green 
fluorescence was detected with a L5 filter cube (ex. 480/40, 
em. 527/30) using an exposure time of 60 ms and a gain of 2. 
The red fluorescence was detected with a N3 cube (ex. 
546/12, em. 600/40) with similar exposure time and gain. 
This resulted in two fluorescence images, one for the green 
and one for the red fluorescence. The quantitative analysis of 
the images was done with the free ware program ImageJ. 
Therefore each image was transformed into a 8-bit picture. 
After that a macro (the code of the macro is shown below) 
counted the fluorescent cells within the picture. 
>macro QuantSlide{ 
> w = getWidth(); 
> h = getHeight(); 
> treshold = 30; 
> counter = 0; 
> for (i=0; i<w; i++){ 
>       for (j=0; j<h; j++){ 
>           a = getPixel(i,j); 
>           if (a>=treshold) { 
>               counter = counter +1; 
>           } 
>       } 
> } 
The viability was determined as followed: 
                
                            
                                               
 (3) 
2.9. Statistical Analysis 
 For all quantitative data mean and standard deviation 
were calculated. To compare the mean values a t-test (two 
sample test with known variances) was performed. A p-value 
under 0.05 was deemed to indicate a statistically significant 
difference. 
3. RESULTS AND DISCUSSION 
 The main objective of this work was to investigate 
different detachment enzymes for the harvest of therapeutic 
hMSCs grown in dynamic systems. hMSC-TERT was 
chosen as a model cell line as these cells are already used in 
cell therapy approaches. hMSCs in general are strictly 
adherent cells, so that the expansion has to be performed on 
growth surfaces such as flasks or carriers. The unique factor 
in the production process of these cells is that after 
expansion, the cells have to be detached. As the cells are 
products of the expansion process, the harvest should be 
gentle but effective to yield large amounts of viable cells. 
This study examines which commercial available enzymes of 
non-mammalian origin are suitable for the detachment of 
hMSC-TERT cells. To improve the comparability of the 
results, the same enzyme concentration per cm
2
 was used in 
static and dynamic systems. The first experiments were 
performed in static systems (well plates) to select one or two 
candidate enzymes for further experiments. Then, hMSC-
TERT cells were expanded in different dynamic systems 
(fixed-bed reactor, STR) and harvested. The outcome of the 
harvest was analyzed in terms of the yield and viability of 
the detached cells. As these cells are further processed after 
the harvest, the cells were encapsulated in alginate. These 
cell capsules are the final cell therapy product that should be 
implanted into the patient. Viability staining was performed 
to analyze the cell quality in the capsule. 
3.1. Suitability of the Chosen Enzymes for hMSC-TERT 
Detachment from Static Systems 
 Considering various criteria for the production of stem 
cell-based ATMPs, four different enzymes have been chosen 
for investigations of the enzymatic harvest of adherent 
hMSC-TERT: Accutase
TM
, Alfazyme, Collagenase and 
TrypZean
TM
. In the initial experiments, hMSC-TERT grown 
as a monolayer in static well plates were detached. The cells 
were detached from a borosilicate glass surface to mimic the 
surface conditions of the dynamic systems where the cells 
grow on glass carriers. The cells were detached at room 
temperature (21°C) for 60 min and the detachment was 
monitored by microscopy and quantified by counting the 
harvested cells. As shown in Fig. (1), only Accutase
TM
 and 
TrypZean
TM
 were able to completely detach the hMSC-
TERT cells. In comparison, TrypZean
TM 
was slightly more 
efficient, requiring
 
only 8 min instead of 11 min for 100 % 
detachment. The other two proteolytic enzymes Alfazyme 
and Collagenase seemed not to be suitable for hMSC-TERT 
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detachment from glass surfaces. Even after 60 min 
incubation, these enzymes were only able to detach 30 % of 
the cells at best. 
 Microscopic observation of the detachment reaction with 
Alfazyme and Collagenase (Fig. 1) showed that Alfazyme 
was not able to disrupt the cell-cell contacts, with cells 
detaching from the surface as cell sheets. This implied that 
Alfazyme was not able to split hMSC-TERT cadherins 
which are mainly involved in cell-cell-adhesion. Collagenase 
was able to separate cells but not to detach them from the 
surface. In consequence collagen was not involved in hMSC-
TERT-substrate-adhesion. Following out of the four enzyme 
candidates only Accutase
TM
 and TrypZean
TM
 were used for 
further investigations. 
3.2. Influence of Enzyme Incubation Time on hMSC-
TERT Detachment from Static Systems 
 The initial results showed that Accutase
TM
 and 
TrypZean
TM
 are the most promising candidates for further 
investigation. As high amounts of hMSC-TERT are required 
for therapeutic use, the cells were exposed to each enzyme 
for 20 or 45 min. This long incubation time might be 
necessary for an efficient hMSC-TERT detachment in the 
dynamic FBR and STR systems, because in general cells 
grown on carriers require longer incubation times to be 
detached than cells grown in static monolayers [5]. With this 
experiment it should be investigated if these long enzyme 
incubation times might damage the hMSC-TERT. As control 
porcine trypsin under standard condition (21°C, 10min 
incubation) was used. As shown before, cells were 
completely detached after ~11 minutes. Interestingly, even 
after 45 min incubation with these proteolytic enzymes, no 
decrease in cell viability occurred. This means that direct 
after the detachment no cell damage could be detached with 
Trypan blue staining. The decisive experiment is to evaluate 
the detachment quality by measuring cell viability after cell 
encapsulation. Because of their potential use in cell 
therapeutic approaches, the cells have to have a viability of 
at least 90 % after encapsulation. This is challenging as the 
encapsulation procedure subjects the cells to further stress 
because cells are sheared through drain tubes and are 
influenced by changes in the osmotic environment and other 
stresses. Thus, hMSC-TERT were encapsulated in alginate 
after 20 or 45 minutes of enzyme treatment. The capsules 
were analyzed by live-dead staining directly after 
encapsulation and after 24 h and 48 h of static recultivation 
in cell culture medium.  
 As seen in Fig. (2), the detachment in combination with 
the encapsulation procedure exerted a strong influence on 
cell viability. Directly after encapsulation, many cells were 
damaged and cell membranes were disrupted, visible as red 
 
Fig. (1). Proteolytic detachment of hMSC-TERT grown statically as a monolayer on a borosilicate surface. hMSC-TERT were grown to 
80 % confluence in 6-well-plates on a borosilicate surface and washed twice with PBS without Ca2+/Mg2+. One mL of the enzyme solution 
(AccutaseTM ~100 U/mL, Alfazyme (1:6), Collagenase 0.18 U/mL, TrypZeanTM (1:6)) was added and the plates were incubated at room 
temperature (21°C) for at least 60 min. Detachment was documented microscopically and the detached cells were counted; n = 3. 
Microscopic pictures showed the detachment result for Alfazyme (left) and Collagenase (right) after 60 min enzyme incubation. 
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colored (= damaged) cells. During the recultivation period, 
cell membranes were able to regenerate, as the number of 
green colored (= live) cells increased with recultivation time. 
The degree of cell damage increased with incubation time for 
detachment with TrypZean
TM 
(20 min detachment: 
91.2 ± 1.6 % viability; 45 min detachment: 69.4 ± 2.8 % 
viability, p < 0.01). This was also the case for detachment 
with Accutase
TM
 but less pronounced (20 min detachment: 
99.5 ± 1.8 % viability; 45 min detachment: 95.1 ± 1.3 % 
viability, p < 0.05)), supporting the argument that 
Accutase
TM
 seems to be gentler to the cells and less 
destructive to the cell surface and membrane proteins [11]. 
The standard cell culture detachment procedure (trypsin, 
10 min incubation, 21°C) led to a slight decrease in the cell 
viability (95.8 ± 1.4 %) of the encapsulated cells. During 
recultivation the viability of the encapsulated cells could 
recover to 99.2 ± 0.8 % (p < 0.05). Note that the detachment 
enzyme and the length of the incubation only affect cell 
viability after harvest if the cells are processed further. 
Directly after the detachment, the cell viability remained 
high in all cases. An influence of the detachment procedure 
on cell viability could only be observed if the cells were 
encapsulated. 
3.3. Influence of Enzyme Incubation Temperature on 
hMSC-TERT Detachment from Static Systems 
 In general, detachment enzymes are optimally active at 
37°C. This could be superior for cell detachment yield in 
dynamic systems as enzymes work more efficient. In 
contrast increasing the reaction temperature is likely to 
increase the potential proteolytic damage of the cells. To 
evaluate that influence, hMSC-TERT detachment was 
analyzed at 37°C. The same experimental setup and 
conditions were used as in the previous experiment. The 
results are presented in Fig. (3). 
 hMSC-TERT harvested at 37°C and then encapsulated 
mostly exhibited viabilities below 50 % after 48 hours of 
cultivation in alginate capsules, whereas at room temperature 
the cells in the capsules had viabilities > 95 %. After 20 min 
detachment with Accutase
TM
 at 37°C and subsequent 
encapsulation, first the amount of viable cells was 
97.0 ± 1.2 %. During recultivation of the cell capsules the 
viability dropped down to 43.3 ± 5.2 % (p < 0.01). Better 
results were observed for TrypZean
TM
. Although after 
20 min TrypZean
TM
 treatment cell viability of the capsules 
was lower (direct after encapsulation: 84.5 ± 2.6 %), the cells 
were able to regenerate during the recultivation period, 
yielding to a cell viability of 95.7 ± 1.2 % (p < 0.01). 
 
Fig. (2). hMSC-TERT encapsulated in alginate after enzymatic detachment from borosilicate surfaces in 6-well plates (21°C). hMSC-TERT 
cells were grown to 80 % confluence in 6-well-plates on a borosilicate surface and washed twice with PBS without Ca2+/Mg2+. The enzyme 
solution (0.13 mL/cm2; AccutaseTM ~100 U/mL, TrypZeanTM (1:6) orTrypsin) was added and the plates were incubated at room temperature 
(21°C) for 20 or 45 min. Detached cells were encapsulated in alginate. The capsules were recultivated in hMSC-TERT culture medium in 6-
well-plates for 48 h at 37°C. The cell viability was analyzed by performing live-dead staining. Viable/intact cells were stained green whereas 
damaged/dead cells were stained red. 
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However, after 45 min incubation, the cell viability 
continuously decreased during the recultivation period for 
both enzymes (Accutase
TM
: 92.6 ± 3.4 % (0h)-77.5 ± 4.8 % 
(24h)-35.1 ± 2.5 % (48h), p < 0.01; TrypZean
TM
: 97.5 ± 1.0  
% (0h)-88.7 ± 1.5 % (24h)-47.3 ± 4.9 % (48h), p < 0.01), a 
good indication that cell damage was already present at the 
beginning of this period. Poor results were observed for the 
standard detachment enzyme trypsin. After 10 min trypsin 
detachment followed by encapsulation, cell membranes were 
disrupted as seen by the majority of red colored cells in Fig. 
(3) (cell viability direct after encapsulation 8.3 ± 1.4 %). 
Some of these cells could be recovered, but the cell viability 
was still low after recultivation (cell viability during 
recultivation 73.8 ± 2.1 % (24h), 64.8 ± 3.6 % (48h)). This 
investigation leads to the conclusion that the temperature 
during enzymatic harvest and the duration of enzyme 
exposure had significant impacts on the cell viability after 
detachment followed by encapsulation. For this type of 
production process and both investigated enzymes, 
detachment at room temperature (21°C) with a maximum 
incubation time of 20 minutes was superior for the survival 
of the encapsulated hMSC-TERT. This led to cell capsules 
with viabilities of 99 %. This gave a good basis for the 
experiments in the dynamic systems.  
3.4. Harvest of hMSC-TERT Expanded in a Fixed-Bed 
Reactor 
 The problem of balancing the detachment yield, which 
should be 100 %, and the applied cell stress induced by the 
detachment procedure, which should be minimal, is more 
complex in dynamic systems. To expand larger amounts of 
stem cells for therapeutic approaches, controlled bioreactor 
systems will need to be used such as fixed-bed or stirred tank 
reactors. Harvesting cells from these reactor systems has 
received relatively little study because in most biotech-
nological processes, cell detachment is not required. 
Therefore, most carriers for these systems, which are 
obligatory for stem cell expansion, are designed to promote 
strong adherence but not detachment. In previous studies, 
our workgroup identified carriers combining both 
characteristics: good attachment and growth of the hMSC-
TERT and enabling hMSC-TERT detachment [5]. With 
these glass carriers, a fixed-bed based expansion system for 
hMSC-TERT was set up [6, 7]. Detailed studies of the 
detachment of the hMSC-TERT from this FBR were 
conducted using similar conditions to the static experiments 
described above. Based on the previous results, only 
Accutase
TM
 and TrypZean
TM
 at 21°C with incubation times 
from 10 to 20 minutes were analyzed. Harvested cells were 
 
Fig. (3). hMSC-TERT encapsulated in alginate after enzymatic detachment from borosilicate surfaces in 6-well plates (37°C). hMSC-TERT 
were grown to 80 % confluence in 6-well-plates on a borosilicate surface and washed twice with PBS without Ca2+/Mg2+. The enzyme 
solution (0.13 mL/cm2; AccutaseTM ~100 U/mL, TrypZeanTM (1:6) or Trypsin) was added and the plates were incubated at 37°C for 20 or 
45 min. Detached cells were encapsulated in alginate. The capsules were recultivated in hMSC-TERT culture medium in 6-well-plates for 
48 h at 37°C. The cell viability was analyzed using live-dead staining. Viable/intact cells were stained green whereas damaged/dead cells 
were stained red. 
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further processed to alginate capsules and analyzed as 
described previously. 
 The first basic difference from the detachment 
experiments with the hMSC-TERT cells grown as 
monolayers in static systems (well plates) is that the harvest 
from the FBR was not that efficient (Table 2). A maximum 
of ~70 % of the hMSC-TERT grown in the FBR could be 
detached within the selected experimental conditions. Note 
that 100 % detachment was reachable, but only with a 
dramatic loss in cell viability. 
 That cell viability is influenced more by hMSC-TERT 
detachment from FBR than by static cultivation systems as 
shown in Fig. (4). In dynamic systems, the detachment 
procedure results in other shear forces because the cells are 
flushed out of the system. Although a superficial velocity 
that should not affect cell viability was used [6], the duration 
of shear is longer compared to static systems. hMSC-TERT 
detached after 10 min Accutase
TM
 treatment in the FBR 
exhibited very low viabilities after encapsulation with high 
standard deviations (7.0 ± 6.8 % (0h)-9.4 ± 8.6 % (24h)-
21.21 ± 20.7 % (48h), p < 0.01). When the detachment yield 
was relatively low (24 %), 13.9 % of the hMSC-TERT in the 
alginate capsules stayed viable. Cell viability did only partly 
recover during recultivation, indicating that 60% of the red 
colored cells were dead right after detachment and 
encapsulation (Fig. (4), left hand). In one case, the harvest 
yield was over 80 %, but these cells were completely dead 
(Fig. (4), right hand). The cell viability of the encapsulated 
cells was max. 0.4% and could not recover during 
recultivation. Microscopic observation of the detachment 
showed that in this case, cells were not detached as single 
cells but rather torn off as cell sheets. The resulting shear 
forces were too high for cell survival. After 20 min of 
Accutase
TM
 treatment in the FBR the results were more 
homogenous, but both the detachment yield (59 ± 5 %) and 
cell viability of hMSC-TERT after encapsulation were 
unsatisfactory (52.6 ± 4.7 % after encapsulation and 48h 
recultivation). hMSC-TERT grown in the FBR, detached 
with TrypZean
TM 
and encapsulated exhibited a high viability 
right after the encapsulation for all investigated incubation 
times (10 min: 97.8 ± 1.5 %, 15 min 89.3 ± 3.1 % and 
20 min 92.4 ± 2.1 %). Unfortunately, after 10 min 
detachment, the cell viability decreased during recultivation 
down to 63.0 ± 2.1 %, indicating the presence of cell 
damage. This could result from the incomplete detachment 
of the cells. Cells were not gently flushed out of the FBR but 
were rather partially torn off. After 20 min detachment the 
similar decrease of cell viability during recultivation was 
observed but the reason for that might be different. In this 
 
Fig. (4). hMSC-TERT encapsulated in alginate after enzymatic detachment from borosilicate carriers in a fixed-bed reactor (21°C). hMSC-
TERT were grown in an 100 cm3 FBR and washed twice with PBS without Ca2+/Mg2+. The enzyme solution (0.13 mL/cm2, AccutaseTM 
~600 U/mL or TrypZeanTM) was added and the carriers were incubated at room temperature (21°C) for 10,15 or 20 min. Detached cells were 
encapsulated in alginate. The capsules were recultivated in hMSC-TERT culture medium in 6-well-plates for 48 h at 37°C. The cell viability 
was assessed using live-dead staining. Viable/intact cells were stained green whereas damaged/dead cells were stained red. 
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case, it is more likely that during the longer incubation time, 
TrypZean
TM
 damaged the surface proteins of the hMSC-
TERT, leading to subsequent cell death. Only hMSC-TERT 
detached after 15 min TrypZean
TM
 treatment retained a high 
viability after encapsulation (89.3 ± 3.1 % (0h)-87.4 ± 5.7 % 
(24h)-81.0 ± 1.9 % (48h)). Nonetheless, the harvest yield 
was only 41 ± 4 % for that scenario. 
 The detachment experiments of hMSC-TERT grown in 
an FBR demonstrated the difficulties of this process. The 
good preliminary results after detachment with Accutase
TM
 
and TrypZean
TM
 in static well plates were not transferable to 
the dynamic situation in the FBR. Cell growth in the FBR 
differs depending on the heterogeneity of the system and the 
heightened shear stress compared to static cell growth. This 
environment reduces growth rate (µ = 0.37 ± 0.01 d-1) when 
compared to a static system (µ = 0.52 ± 0.07 d-1, p<0.05). 
The preloading of the cells depending on the cultivation 
environment combined with the higher shear levels during 
harvest in the FBR are one explanation for the differences in 
results in the static and the dynamic FBR system. One thing 
is certain, the heterogeneity in the FBR leads to a 
heterogeneous distribution of the enzyme in the reactor. 
These large enzyme concentration differences inside the 
fixed-bed result in different detachment zones. In a high 
enzyme concentration zone, detachment can be complete, 
whereas in a low enzyme concentration zone, the cells can 
still be attached and then torn off when medium is flushed 
through the FBR. Thus, the harvest yield from the FBR and 
the cell viability of the detached and encapsulated cells were 
significantly lower. For a therapeutic approach, encapsulated 
hMSC-TERT need to have cell viabilities exceeding 90 %, 
which should stay stable during recultivation. In combination 
with the conditions in the FBR, neither of the two enzymes 
could fulfill all the requirements for hMSC-TERT 
detachment to enable therapeutic applications of these cells 
as capsules. 
3.5. Harvest of hMSC-TERT Expanded in a Stirred Tank 
Reactor 
 As described above, it was difficult to harvest hMSC-
TERT from the FBR. This was due to the heterogeneity and 
the shearing in the reactor. As the situation in a stirred tank 
reactor (STR) is more homogenous, the hMSC-TERT 
expansion and detachment was set up in a STR system [3, 8]. 
Similar to the FBR the growth surface was provided by 
glass-coated carriers. To minimize shear stresses from the 
dynamic cultivation mode, a low-shearing marine impeller 
with low agitation was used. The higher homogeneity in the 
STR should allow for a homogenous distribution of the 
detachment enzyme and thus a more homogenous cell 
detachment. As the detachment with TrypZean
TM
 (21°C, 
15 minutes incubation) gave the best outcome for hMSC-
TERT harvest from the FBR, only this condition was 
investigated for hMSC-TERT expanded in the STR. With 
this experimental setup, 68 ± 13 % (n = 3) of the cells grown 
in the STR could be detached. This was high compared to 
the harvest using same conditions from the FBR, but leaves 
room for improvement, as 100 % harvest yields are desired. 
The detached hMSC-TERT expanded in the STR exhibited 
high viability >99% after encapsulation (Fig. 5). The 
viability remained constant over the whole recultivation 
period, indicating more gentle conditions during harvest. 
These results indicated that greater homogeneity inside the 
STR seemed to be preferable for the hMSC-TERT harvest. 
Although detachment yield still needs to be increased, the 
quality of the detached and encapsulated hMSC-TERT was 
satisfactory for an application of the cell capsules as ATMP. 
CONCLUSION 
 To enable broad usage of hMSCs as ATMPs, expansion 
processes have to be established and evaluated to ensure 
efficiency, reproducibility, stability and the desired 
outcomes. In this special case, the outcome is strongly 
connected to the quantity and quality of the expanded cells. 
As hMSCs represent the final product, the cell detachment 
and further processing are highly significant due to their 
direct effects on the product quality. Therefore, the 
detachment cannot be analyzed as a single event, but rather 
must be considered in combination with the expansion and 
encapsulation procedure to achieve meaningful results. With 
respect to the whole process the detachment yield and the 
hMSC viability is influenced by: 
 the detachment enzyme (enzyme must cut proteins 
responsible for cell-cell- and cell-substrate-adhesion, 
should not damage cells) 
 the enzyme incubation parameters (concentration, 
temperature, duration; maximize detachment yield and 
minimize cell damage) 
Table 2. Detachment/Harvest yield from a Fixed bed Reactor. hMSC-TERT Cells Were Grown in an 100 cm3 FBR, and then 
Washed Twice with PBS Without Ca2+/Mg2+. The Enzyme Solution (30 mL, AccutaseTM ~600 U/mL or TrypZeanTM) was 
Added and the Cells in the FBR were Incubated at Room Temperature (21°C) for 10, 15 or 20 min. Detached Cells were 
Counted by a Hemacytometer. Harvest yield was Calculated from the Cell Number before Detachment (Calculated as 
Described in [4]) and the Cell Number after Detachment 
tdetachment 
Detachment yield [%] 
AccutaseTM TrypZeanTM 
10 min 53 ± 29 43 ± 11 
15 min n.d. 41 ± 4* 
20 min 59 ± 5* 69 ± 9 
n.d. not detected, n =3, * n= 2 
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 the cell growth surface (should allow both attachment 
and detachment) 
 using static or dynamic expansion (dynamic expansion 
often higher cell shearing, decreases cell viability after 
detachment) 
 the homogeneity in the expansion system (homogenous 
distribution of the enzyme solution important) 
 further processing of the cells after detachment (any 
processing step increases shear load of the cells and 
thus could decrease cell viability) 
 This study investigated some of these influence factors 
on hMSC-TERT detachment. A suitable growth surface 
allowing cell attachment, growth and detachment had been 
identified in previous studies. For hMSC-TERT borosilicate 
glass was ideal giving high growth rates and high 
detachment yields [5]. For the enzyme choice, first the 
enzymes had to fulfill the basic requirements for hMSC 
harvest for ATMP production. Out of four commercially 
available detachment enzymes (Accutase
TM
, Alfazyme, 
Collagenase and TrypZean
TM
), Collagenase and Alfazyme 
were excluded due to low detachment yields. For the 
remaining two enzymes incubation parameters (temperature, 
duration) were varied. To conclude a general finding which 
parameters were best is difficult. Using same parameters, 
detachment yield differs between the static and dynamic 
cultivation mode and between different reactor systems 
(FBR, STR). 100 % of the cells were live detached from 
static systems after 10 min at 21°C. Complete cell 
detachment in dynamic systems was only possible with a 
loss in cell viability. Moreover cell viability was not only 
depended on the incubation parameters but mainly on further 
cell processing. This was shown as in most cases hMSC-
TERT were highly viable direct after cell detachment. Only 
if hMSC-TERT were further processed (in this study 
encapsulated with alginate) a decrease in cell viability with 
increasing detachment temperature and duration could be 
detected. Accutase
TM
, which worked well in the static 
monolayer experiments, was found to be unsuitable for 
hMSC-TERT detachment from the dynamic FBR. 
TrypZean
TM
 yielded more promising results after 15 min 
enzyme exposure in both dynamic reactor systems (FBR, 
STR). Providing that dynamic hMSC-TERT expansion 
should be favored and detached hMSC-TERT should be 
encapsulated, an expansion in a STR using glass-coated 
carriers with a subsequent detachment using TrypZean
TM
 
(incubation 15 min, 21°C) gave the best outcome. With this 
scenario a detachment yield of 68 % and cell viabilities after 
encapsulation about 99 % could be achieved. 
 Finally, the problem of cell detachment in an ATMP 
production process cannot be solved by choosing the right 
enzyme and its incubation conditions alone. Taking account 
of the shear stress in the expansion system and coordinating 
all steps in up- and downstream processing with respect to 
final ATMP quality are just as important. Further study 
should be devoted to determining whether other growth 
surfaces such as thermo responsive surfaces [23] can 
improve the detachment outcome from dynamic expansion 
systems, alone or in combination with a detachment 
enzymes. This issue must be solved if new enzymes from 
non-mammalian sources show more potential for a gentle but 
effective cell harvest from dynamic systems. At a minimum, 
problems of this nature in reactor set up have to be solved, as 
STR are not equipped for the detachment of cells from the 
carrier. Therefore, solutions can be sieve modifications as 
previously described by our workgroup [24]. 
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Fig. (5). hMSC-TERT encapsulated in alginate after enzymatic detachment from borosilicate carriers in a stirred tank reactor (21°C). hMSC-
TERT were grown in a 3 L STR, washed twice with PBS without Ca2+/Mg2+. The enzyme solution (0.13 mL/cm2, TrypZeanTM) was added 
and the carriers were incubated at room temperature (21°C) for 15 min. Detached cells were encapsulated in alginate. The capsules were 
recultivated in hMSC-TERT culture medium in 6-well-plates for 48 h at 37°C. The cell viability was analyzed by live-dead staining. 
Viable/intact cells were stained green whereas damaged/dead cells were stained red. 
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